Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep Apnea, Obstructive | 14 | 2017 | 205 | 1.500 |
Why?
|
| Palatine Tonsil | 8 | 2010 | 36 | 1.030 |
Why?
|
| Adenoids | 6 | 2010 | 12 | 0.890 |
Why?
|
| Hypoxia | 8 | 2012 | 248 | 0.850 |
Why?
|
| Sleep Apnea Syndromes | 3 | 2012 | 75 | 0.510 |
Why?
|
| Polysomnography | 8 | 2011 | 145 | 0.510 |
Why?
|
| Adenoidectomy | 5 | 2011 | 76 | 0.410 |
Why?
|
| Snoring | 5 | 2017 | 18 | 0.400 |
Why?
|
| Tonsillectomy | 5 | 2011 | 99 | 0.380 |
Why?
|
| Erythropoietin | 1 | 2012 | 104 | 0.370 |
Why?
|
| Cognition Disorders | 3 | 2012 | 551 | 0.370 |
Why?
|
| Leukotriene Antagonists | 1 | 2008 | 17 | 0.310 |
Why?
|
| Vasculitis | 1 | 2007 | 49 | 0.280 |
Why?
|
| Disease Models, Animal | 5 | 2012 | 4405 | 0.260 |
Why?
|
| Posture | 1 | 2007 | 152 | 0.260 |
Why?
|
| Endothelium, Vascular | 1 | 2007 | 491 | 0.230 |
Why?
|
| Maze Learning | 4 | 2012 | 127 | 0.210 |
Why?
|
| Narcolepsy | 1 | 2022 | 5 | 0.200 |
Why?
|
| NADPH Oxidases | 3 | 2012 | 112 | 0.200 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2022 | 30 | 0.200 |
Why?
|
| Obesity | 3 | 2011 | 2249 | 0.180 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2022 | 178 | 0.180 |
Why?
|
| Embryonic Stem Cells | 2 | 2011 | 163 | 0.160 |
Why?
|
| Child, Preschool | 14 | 2017 | 14123 | 0.160 |
Why?
|
| Bone Marrow Cells | 2 | 2011 | 260 | 0.160 |
Why?
|
| Gene Regulatory Networks | 3 | 2011 | 363 | 0.160 |
Why?
|
| Child | 18 | 2022 | 24575 | 0.150 |
Why?
|
| Hypertrophy | 5 | 2010 | 104 | 0.150 |
Why?
|
| Cells, Cultured | 4 | 2012 | 3041 | 0.140 |
Why?
|
| Tick Paralysis | 1 | 2017 | 1 | 0.140 |
Why?
|
| Tick-Borne Diseases | 1 | 2017 | 10 | 0.140 |
Why?
|
| Influenza Vaccines | 1 | 2022 | 481 | 0.140 |
Why?
|
| Lipid Peroxidation | 3 | 2012 | 96 | 0.140 |
Why?
|
| Severity of Illness Index | 6 | 2017 | 2906 | 0.140 |
Why?
|
| DiGeorge Syndrome | 1 | 2017 | 80 | 0.130 |
Why?
|
| Muscle Weakness | 1 | 2017 | 84 | 0.130 |
Why?
|
| Oximetry | 1 | 2017 | 171 | 0.130 |
Why?
|
| Sleep | 3 | 2022 | 346 | 0.130 |
Why?
|
| Male | 24 | 2022 | 61573 | 0.130 |
Why?
|
| Influenza, Human | 1 | 2022 | 662 | 0.130 |
Why?
|
| Deoxyguanosine | 2 | 2012 | 13 | 0.120 |
Why?
|
| Epilepsy | 2 | 2017 | 874 | 0.120 |
Why?
|
| Swimming | 2 | 2012 | 22 | 0.120 |
Why?
|
| Cell Proliferation | 4 | 2009 | 2371 | 0.120 |
Why?
|
| Gene Expression Regulation | 4 | 2012 | 2522 | 0.120 |
Why?
|
| Analysis of Variance | 3 | 2012 | 1018 | 0.120 |
Why?
|
| Case-Control Studies | 4 | 2010 | 3309 | 0.110 |
Why?
|
| Cell Culture Techniques | 3 | 2009 | 276 | 0.110 |
Why?
|
| Tonsillitis | 2 | 2010 | 13 | 0.100 |
Why?
|
| Women | 1 | 2012 | 15 | 0.100 |
Why?
|
| Escape Reaction | 1 | 2012 | 15 | 0.100 |
Why?
|
| Injections, Intraperitoneal | 1 | 2012 | 75 | 0.100 |
Why?
|
| Malondialdehyde | 1 | 2012 | 60 | 0.100 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2012 | 31 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 5 | 2012 | 4418 | 0.100 |
Why?
|
| Female | 18 | 2022 | 66836 | 0.090 |
Why?
|
| Evoked Potentials | 2 | 2009 | 145 | 0.090 |
Why?
|
| Cell Shape | 1 | 2011 | 62 | 0.090 |
Why?
|
| Humans | 22 | 2022 | 125331 | 0.090 |
Why?
|
| Actigraphy | 1 | 2011 | 45 | 0.090 |
Why?
|
| Pluripotent Stem Cells | 1 | 2011 | 71 | 0.090 |
Why?
|
| Circadian Rhythm | 1 | 2012 | 274 | 0.080 |
Why?
|
| Embryo, Mammalian | 1 | 2012 | 455 | 0.080 |
Why?
|
| Bronchiolitis, Viral | 1 | 2009 | 30 | 0.080 |
Why?
|
| Time Factors | 4 | 2012 | 6318 | 0.080 |
Why?
|
| Gene Expression Profiling | 3 | 2011 | 1756 | 0.080 |
Why?
|
| Cytokines | 3 | 2009 | 1288 | 0.080 |
Why?
|
| SRS-A | 1 | 2008 | 1 | 0.080 |
Why?
|
| Leukotriene D4 | 1 | 2008 | 6 | 0.080 |
Why?
|
| Cerebral Cortex | 1 | 2012 | 455 | 0.080 |
Why?
|
| Adaptation, Psychological | 1 | 2012 | 449 | 0.080 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2010 | 117 | 0.080 |
Why?
|
| Sulfides | 1 | 2008 | 21 | 0.080 |
Why?
|
| Memory | 1 | 2012 | 359 | 0.080 |
Why?
|
| Membrane Glycoproteins | 1 | 2011 | 413 | 0.080 |
Why?
|
| Androstadienes | 1 | 2008 | 50 | 0.080 |
Why?
|
| Acetates | 1 | 2008 | 73 | 0.080 |
Why?
|
| Cyclopropanes | 1 | 2008 | 67 | 0.080 |
Why?
|
| RNA Polymerase II | 1 | 2008 | 100 | 0.070 |
Why?
|
| Hydroxyurea | 1 | 2008 | 83 | 0.070 |
Why?
|
| Catechin | 1 | 2008 | 13 | 0.070 |
Why?
|
| Quinolines | 1 | 2008 | 103 | 0.070 |
Why?
|
| Interleukins | 1 | 2008 | 120 | 0.070 |
Why?
|
| Apoptosis | 3 | 2010 | 1816 | 0.070 |
Why?
|
| Hyperemia | 1 | 2007 | 27 | 0.070 |
Why?
|
| Middle Ear Ventilation | 1 | 2007 | 29 | 0.070 |
Why?
|
| CD40 Ligand | 1 | 2007 | 62 | 0.070 |
Why?
|
| Tyrosine | 1 | 2007 | 150 | 0.070 |
Why?
|
| Otolaryngology | 1 | 2009 | 106 | 0.070 |
Why?
|
| Stress, Psychological | 1 | 2012 | 558 | 0.070 |
Why?
|
| Attention | 1 | 2009 | 202 | 0.070 |
Why?
|
| Otitis Media | 1 | 2007 | 85 | 0.070 |
Why?
|
| Dexamethasone | 1 | 2008 | 274 | 0.070 |
Why?
|
| Prefrontal Cortex | 1 | 2008 | 184 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 587 | 0.070 |
Why?
|
| Adolescent | 5 | 2017 | 19419 | 0.070 |
Why?
|
| Plant Extracts | 1 | 2008 | 119 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2008 | 292 | 0.060 |
Why?
|
| Body Mass Index | 2 | 2009 | 1562 | 0.060 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2009 | 345 | 0.060 |
Why?
|
| Hippocampus | 2 | 2008 | 825 | 0.060 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2009 | 224 | 0.060 |
Why?
|
| Glucocorticoids | 1 | 2008 | 384 | 0.060 |
Why?
|
| Referral and Consultation | 1 | 2009 | 542 | 0.060 |
Why?
|
| Arginine | 1 | 2007 | 334 | 0.060 |
Why?
|
| Sleep Wake Disorders | 1 | 2007 | 168 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 1703 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 1691 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2011 | 2810 | 0.060 |
Why?
|
| Infant | 3 | 2009 | 12581 | 0.060 |
Why?
|
| Mice | 5 | 2012 | 17736 | 0.060 |
Why?
|
| Nitric Oxide | 1 | 2007 | 485 | 0.060 |
Why?
|
| Asthma | 1 | 2011 | 756 | 0.050 |
Why?
|
| Body Weight | 1 | 2007 | 989 | 0.050 |
Why?
|
| Cognition | 1 | 2008 | 728 | 0.050 |
Why?
|
| Animals | 7 | 2012 | 34298 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2009 | 4837 | 0.050 |
Why?
|
| Primary Health Care | 1 | 2009 | 774 | 0.050 |
Why?
|
| Risk Factors | 4 | 2009 | 10287 | 0.050 |
Why?
|
| Age Factors | 1 | 2009 | 2824 | 0.050 |
Why?
|
| Neurons | 1 | 2012 | 1941 | 0.050 |
Why?
|
| Inflammation | 1 | 2009 | 1444 | 0.050 |
Why?
|
| Lung | 1 | 2008 | 1487 | 0.040 |
Why?
|
| Chemokines | 2 | 2011 | 133 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 2518 | 0.040 |
Why?
|
| Comorbidity | 3 | 2011 | 1531 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2022 | 6160 | 0.040 |
Why?
|
| Microarray Analysis | 2 | 2010 | 237 | 0.040 |
Why?
|
| Kentucky | 2 | 2007 | 28 | 0.040 |
Why?
|
| Rats | 3 | 2008 | 3725 | 0.040 |
Why?
|
| Flow Cytometry | 2 | 2010 | 801 | 0.030 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2017 | 45 | 0.030 |
Why?
|
| Vaccination | 1 | 2022 | 962 | 0.030 |
Why?
|
| Electromyography | 1 | 2017 | 163 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2009 | 822 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 3603 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2008 | 1242 | 0.030 |
Why?
|
| Incidence | 1 | 2022 | 3134 | 0.030 |
Why?
|
| Recurrence | 2 | 2009 | 1391 | 0.030 |
Why?
|
| Neuropsychological Tests | 2 | 2009 | 922 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2017 | 3741 | 0.030 |
Why?
|
| Electroencephalography | 2 | 2009 | 866 | 0.030 |
Why?
|
| NADPH Oxidase 2 | 1 | 2011 | 40 | 0.020 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2010 | 28 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 2901 | 0.020 |
Why?
|
| Algorithms | 1 | 2017 | 1632 | 0.020 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2010 | 30 | 0.020 |
Why?
|
| Chemokine CXCL12 | 1 | 2010 | 37 | 0.020 |
Why?
|
| Wakefulness | 1 | 2011 | 97 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2010 | 146 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 67 | 0.020 |
Why?
|
| Phenotype | 2 | 2011 | 4268 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2010 | 137 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2022 | 16344 | 0.020 |
Why?
|
| Self Report | 1 | 2012 | 515 | 0.020 |
Why?
|
| Retinol-Binding Proteins, Cellular | 1 | 2008 | 2 | 0.020 |
Why?
|
| Fluticasone | 1 | 2008 | 15 | 0.020 |
Why?
|
| PC12 Cells | 1 | 2008 | 25 | 0.020 |
Why?
|
| Cullin Proteins | 1 | 2008 | 14 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2007 | 3431 | 0.020 |
Why?
|
| Adult | 3 | 2017 | 29607 | 0.020 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2008 | 36 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2010 | 188 | 0.020 |
Why?
|
| Tea | 1 | 2008 | 15 | 0.020 |
Why?
|
| Serine | 1 | 2008 | 175 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 1033 | 0.020 |
Why?
|
| Age Distribution | 1 | 2009 | 417 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 434 | 0.020 |
Why?
|
| Cell Movement | 1 | 2011 | 854 | 0.020 |
Why?
|
| Causality | 1 | 2007 | 84 | 0.020 |
Why?
|
| Sleep Stages | 1 | 2007 | 32 | 0.020 |
Why?
|
| Child Behavior Disorders | 1 | 2007 | 66 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 2007 | 113 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2009 | 560 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2009 | 533 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2010 | 537 | 0.020 |
Why?
|
| RNA | 1 | 2010 | 573 | 0.020 |
Why?
|
| Computational Biology | 1 | 2011 | 819 | 0.020 |
Why?
|
| Reference Values | 1 | 2007 | 717 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2009 | 817 | 0.020 |
Why?
|
| Brain | 1 | 2017 | 3009 | 0.020 |
Why?
|
| Genotype | 1 | 2011 | 2569 | 0.010 |
Why?
|
| Estrogen Receptor alpha | 1 | 2008 | 458 | 0.010 |
Why?
|
| Disease Progression | 1 | 2011 | 2081 | 0.010 |
Why?
|
| Prevalence | 1 | 2011 | 2466 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2008 | 1033 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2011 | 3751 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2008 | 818 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2009 | 1537 | 0.010 |
Why?
|
| Parents | 1 | 2009 | 1023 | 0.010 |
Why?
|
| Biomarkers | 1 | 2010 | 3093 | 0.010 |
Why?
|
| Quality of Life | 1 | 2011 | 1946 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2009 | 1719 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2011 | 12290 | 0.010 |
Why?
|
| Aged | 1 | 2012 | 19728 | 0.010 |
Why?
|
| Middle Aged | 1 | 2012 | 26807 | 0.010 |
Why?
|